accountthe company said that new paid prescriptions for its drug Acthar in the treatment of certain symptoms of multiple sclerosis were tracking ���substantially��� higher in the second quarter than in the first quarter. U.S.-traded shares of Takeda...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Questcor climbs as drug sector gains
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account